8-K: NorthStar Healthcare Issues Supplemental Disclosures Amidst Stockholder Lawsuits Challenging Merger Details

NorthStar Healthcare Income, Inc. has filed supplemental disclosures to its definitive proxy statement in response to stockholder lawsuits challenging the adequacy of information related to its pending merger with an affiliate of Welltower.

Summary

• NorthStar Healthcare Income, Inc. (NorthStar Healthcare) has filed supplemental disclosures to its Definitive Proxy Statement concerning its merger with Compound Holdco LLC, an affiliate of Welltower OP LLC.
• The supplemental disclosures were issued in response to four demand letters and two complaints filed by purported stockholders, alleging inadequate disclosures in previous proxy statements related to the merger.
• The company denies the allegations of insufficient disclosure but is providing the additional information voluntarily to avoid potential litigation burden, moot disclosure claims, and prevent delays to the merger.
• The merger agreement, dated January 29, 2025, proposes a cash consideration of $3.03 per share, valuing NorthStar Healthcare's equity at approximately $563 million and gross assets at approximately $935 million.
• During the 'go-shop' period, which began on January 30, 2025, 17 parties were granted access to nonpublic information, but no third party submitted an acquisition proposal prior to its expiration.
• Discussions regarding post-closing employment for NorthStar Healthcare management, specifically Mr. Young, occurred after the go-shop period, but no agreement was reached, and no management members are expected to be employed by the acquirer post-merger.
• The filing includes updated unaudited prospective financial information for NorthStar Healthcare through 2029, including projections for NOI, EBITDA, Capital Expenditures, and Unlevered Cash Flow.

Sentiment

Score: 6

Explanation: The document presents a company actively managing legal challenges to a pre-existing merger agreement. While the lawsuits are a negative, the company's proactive response to mitigate potential delays and provide transparency, coupled with the fact that no superior offers emerged during the go-shop period, suggests a clear path forward for the merger. The financial projections indicate a stable outlook for the underlying assets.

Positives

• The merger offers a clear cash exit for stockholders at $3.03 per share.
• The company is proactively addressing stockholder concerns and litigation risks by voluntarily providing supplemental disclosures, aiming to facilitate the merger's timely completion.
• The 'go-shop' period, although not yielding superior bids, demonstrates the company's effort to explore alternatives and fulfill its fiduciary duties.
• The proposed merger is not subject to a financing condition, reducing a key uncertainty for the transaction.

Negatives

• The existence of four demand letters and two formal complaints from stockholders indicates significant dissatisfaction with prior disclosures and potentially the merger terms.
• No competing acquisition proposals emerged during the 'go-shop' period, suggesting that the current offer may be the only viable option or that other parties were not willing to offer a higher price.
• The necessity of issuing supplemental disclosures, even if voluntary, implies a perceived deficiency in the initial proxy statements by some stakeholders.
• No members of NorthStar Healthcare management are expected to be employed by the acquiring entity post-merger, which could be seen as a negative for the existing leadership team.

Risks

• The ongoing stockholder actions (lawsuits and demand letters) could still lead to litigation burden, costs, or potential delays to the merger, despite the supplemental disclosures.
• There is a risk that the merger may not be consummated due to failure to obtain requisite stockholder approval, regulatory approvals, or other conditions.
• The merger agreement may be terminated under certain circumstances, which could require NorthStar Healthcare to pay a termination fee.
• The proposed merger could disrupt NorthStar Healthcare's current plans and operations, potentially diverting management's attention from ongoing business activities.
• There is a risk that the anticipated benefits of the merger may not be fully realized.
• The announcement of the merger could negatively impact NorthStar Healthcare's ability to retain and hire key personnel and maintain relationships with its managers, residents, and other business partners.
• General business risks and important factors identified in NorthStar Healthcare's other SEC filings (e.g., Form 10-K, 10-Q, 8-K) could cause actual results to differ materially from forward-looking statements.

Future Outlook

The primary future outlook for NorthStar Healthcare is the consummation of its merger with an affiliate of Welltower, subject to stockholder approval at the upcoming Special Meeting on June 4, 2025, and other closing conditions. Management's financial forecasts project continued growth in NOI and EBITDA through 2029, with Unlevered Cash Flow also showing an upward trend, albeit with fluctuations due to capital expenditures. The company anticipates successfully navigating the current stockholder litigation to avoid delays and proceed with the merger as planned.

Management Comments

• "The Company believes that the allegations in the Stockholder Actions are without merit."
• "The Company denies all allegations in the Stockholder Actions, and believes no supplemental disclosure to the Definitive Proxy Statement was or is required under any applicable law, rule or regulation."
• "However, solely to eliminate the burden and expense of potential litigation, to moot certain of plaintiffs disclosure claims, to avoid potential delay or disruption to the Merger, and to provide additional information to the Companys stockholders, the Company has determined to voluntarily supplement the Definitive Proxy Statement with the below disclosures."
• "The Company believes that the disclosures set forth in the Definitive Proxy Statement comply fully with applicable law and nothing in the below supplemental disclosure will be deemed an admission of the legal necessity or materiality under applicable law of any of the disclosures set forth herein."
• "It is expected that no members of NorthStar Healthcare management will be employed by Merger Sub or any other affiliates of Welltower after closing."

Industry Context

NorthStar Healthcare operates within the healthcare real estate investment trust (REIT) sector, a specialized segment of the real estate industry focused on properties like skilled nursing facilities, assisted living facilities, and medical office buildings. The merger with Welltower, a prominent healthcare REIT, reflects a trend of consolidation within the sector, driven by factors such as economies of scale, access to capital, and strategic positioning in a dynamic healthcare landscape. The peer group used for valuation, including Sabra Health Care REIT, American Healthcare REIT, CareTrust REIT, National Health Investors Inc., and LTC Properties Inc., further underscores its position within this specific industry niche.

Comparison to Industry Standards

• The document provides a market valuation peer group including Sabra Health Care REIT, Inc. ($4,003.0M Equity Market Value, $6,410.3M Total Enterprise Value), American Healthcare REIT, Inc. ($4,423.5M Equity Market Value, $6,284.2M Total Enterprise Value), CareTrust REIT, Inc. ($4,613.7M Equity Market Value, $5,077.9M Total Enterprise Value), National Health Investors Inc. ($3,162.3M Equity Market Value, $4,301.5M Total Enterprise Value), and LTC Properties Inc. ($1,495.2M Equity Market Value, $2,339.1M Total Enterprise Value) as of January 24, 2025.
• NorthStar Healthcare's proposed equity value of approximately $563 million and gross asset value of approximately $935 million in the merger can be compared against these peers to assess its relative size and valuation within the healthcare REIT sector.
• The discounted cash flow analysis utilized a range of discount rates from 10.0% to 13.5%, derived using the capital asset pricing model (CAPM), which is a standard valuation methodology in financial analysis.
• The estimated terminal value was calculated using a selected range of entity cap rates of 6.0%-7.0%, which CSCA based in part on the historical entity cap rates of the Peer Group, indicating an alignment with industry valuation practices.

Management Changes

Corporate Governance

Legal Proceedings

• Four demand letters have been sent on behalf of purported Company stockholders challenging the adequacy of certain disclosures in the Preliminary Proxy Statement and the Definitive Proxy Statement.
• Two complaints have been filed on behalf of purported Company stockholders in the Supreme Court of the State of New York, County of New York.
• The complaints are captioned: 'Sullivan v. NorthStar Healthcare Income, Inc., et al., Index No. 652792/2025' and 'Prince v. NorthStar Healthcare Income, Inc., et al., Index No. 652795/2025'.
• The Company believes the allegations are without merit and denies them, stating no supplemental disclosure was legally required, but is providing them voluntarily to avoid litigation and delay.

Stakeholder Impact

• **Shareholders**: Will vote on the merger and, if approved, will receive $3.03 per share in cash. Some shareholders have initiated legal actions challenging the adequacy of merger disclosures.
• **Management**: Current NorthStar Healthcare management is not expected to be employed by the acquiring entity post-merger, indicating a change in leadership structure for the acquired entity.
• **Employees**: While not explicitly detailed, mergers often lead to organizational restructuring that can impact employees.

Next Steps

• NorthStar Healthcare stockholders are scheduled to hold a Special Meeting virtually on June 4, 2025, at 10:00 a.m. Eastern Time to vote on the proposed merger.
• The consummation of the merger is contingent upon stockholder approval and the satisfaction of other terms and conditions outlined in the Merger Agreement.

Key Dates

Recommendation

Keywords

NorthStar Healthcare Income Inc., Welltower, Merger, Acquisition, SEC Filing, 8-K, Proxy Statement, Stockholder Lawsuit, Healthcare REIT, Real Estate, Corporate Governance, Financial Projections, Go-Shop, Litigation